Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Satiro De Oliveira, M.D.
Satiro De Oliveira, M.D.


Pediatric Hematology/Oncology
Pediatric Hematopoietic Stem Cell Transplantation

General Information:

English, Spanish, Portuguese


Clinical Instructor, Department of Pediatrics
Member, JCCC Tumor Immunology Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica


Pediatric Hematology-Oncology, Childrens Hospital of Los Angeles, 2007 - 2010
Pediatric Hematology-Oncology, Boldrini Children's Center, 1999 - 2002
Pediatrics, Woodhull Medical and Mental Health Center, 2004 - 2007
Pediatrics, Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto, Brazil, 1997 - 1999
Internal Medicine, Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto, Brazil, 1995
Medical Degree:
M.D., Faculdade de Medicina da Universidade de Sao Paulo, 1995


Board Certification(s):
Pediatric Hematology/Oncology, American Board of Pediatrics, 2011
Pediatrics, American Board of Pediatrics, 2007

Contact Information:

(310) 825-6708 (office)
(310) 794-1940 (lab)

Practice Information:

Clinical Interest(s):
Hematopoietic Stem Cell Transplantation
Pediatric Leukemias
Congenital Immunodeficiencies

Scientific Interest(s):

Dr. Satiro De Oliveira has been working for many years fighting pediatric cancer, having started his career in Brazil working at a hospital exclusively dedicated to the treatment of children with cancer and blood diseases. After two years of full-time clinical work, De Oliveira realized that the cure of pediatric cancer only will come from continuous research, and decided to restart his career in the United States as a physician scientist.

Under the mentorship of Dr. Donald Kohn, De Oliveira developed protocols for gene transfer into human Hematopoietic Stem and Progenitor Cells (HSPC), in vitro differentiation of human HSPC and functional cell assays. His work has developed novel immunotherapy concepts of using modified HSPC for cancer immunotherapy.

De Oliveira’s research interests are:
  1. Immunotherapy of Leukemias and Lymphomas
  2. Biology of Hematopoietic Stem Cell Transplantation
  3. Immune Reconstitution after Hematopoietic Stem Cell Transplantation and primary immune deficiencies

Selected Cancer-Related Publications:

Rodrigues PC, Oliveira SN, Viana MB, Matsuda EI, Nowill AE, Brandalise SR, Yunes JA. Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemia. Pediatr Blood Cancer. 2007 Aug;49(2):133-8.

Weltman E, Salvajoli JV, Hanriot Rde M, Prisco FE, Oliveira SN, Cruz JC, Borges SR, Lagatta M, Wajsbrot DB. Radiotherapy for pancreatic cancer. [Article in Portuguese] Rev Assoc Med Bras. 2002 Apr-Jun;48(2):118-28.